By Wyatte Grantham-Philips
Federal regulators are warning consumers that now-recalled lots of the Tydemy birth control pill “may have reduced effectiveness” due to decreased levels of a key ingredient of the product.
Lupin Pharmaceuticals, which manufactures Tydemy, notified customers on Saturday that it was voluntarily recalling two batches of the oral contraceptive — after one lot tested low for ascorbic acid and high “for a known impurity.”
Inadequate ascorbic acid “could potentially impact the effectiveness" of the birth control, Lupin said in a company announcement published by the Food and Drug Administration, which could result in unexpected pregnancy.
In an addition alert published by the FDA on Tuesday, regulators confirmed that no reports of adverse effects related to the recalled lots of Tydemy had been reported to date.
Even though this recall impacts just two batches of one brand, it’s important for people using Tydemy birth control pills to check their stock — and contact a health care provider if needed.
The Tydemy lots under recall were distributed across the U.S. from June 2022 through May 2023. The products can be identified by their lot codes — L200183 and L201560 — and expiration dates of January 2024 and September 2024, respectfully.
Lupin is instructing Tydemy patients to continue taking their medication — and immediately contact a health care provider “for advice regarding an alternative contraceptive method," the FDA said, if their birth control was impacted by the recall or if they experience any problems taking the product.
According to Lupin's announcement last week, the company is also notifying wholesalers, distributors, pharmacies and other retailers and is arranging for the return for all of the products impacted by the recall. Contact information for reimbursement requests can be found on the recall notice.
The Associated Press reached out to Lupin for additional comment Thursday.
Prosecutors will dismiss an involuntary manslaughter charge against Alec Baldwin in the fatal 2021 shooting of a cinematographer on the set of the Western film “ Rust," alluding to new revelations in the investigation while cautioning that Baldwin has not been absolved.
U.S. Census data points to a stark divide between millennials who own homes and those who fear they never will. Millennial homeownership reached an all-time high last year, with 51 percent of millennials owning their own homes.
A crowd apparently panicked by gunfire and an electrical explosion stampeded at an event to distribute financial aid during the Muslim holy month of Ramadan in Yemen’s capital late Wednesday, killing at least 78 people and injuring at least 73 others, according to witnesses and Houthi rebel officials.
Two teenagers and a 20-year-old man have been arrested and charged with reckless murder in connection with a shooting that killed four young people at a Sweet Sixteen birthday party in rural Alabama, investigators announced Wednesday.
Andrew Lester, the 84-year-old white man who shot Ralph Yarl, a Black teenager in Kansas City, pleaded not guilty in his first court appearance Wednesday.
The family of Tyre Nichols, who died after a brutal beating by five Memphis police officers, sued the officers and the city of Memphis on Wednesday.
Summer blend isn’t the latest coffee concoction from Starbucks. It’s a type of fuel blend that’s going to cost customers 25 to 35 cents more per gallon more at the pump, and many customers are bracing themselves for a summer fuel spike.
Netflix on Tuesday said it would begin rolling out paid sharing in the U.S. in the second quarter of this year. The news is not a total surprise. Back in January, Netflix confirmed that it would start to crack down on account sharing.
JPMorgan Chase & Co. CEO Jamie Dimon must undergo up to two days of questioning by lawyers handling lawsuits over whether the bank can be held liable in financier Jeffrey Epstein’s sexual abuse of teenage girls and women, a federal judge said Tuesday.
A study published on Tuesday found widespread misuse of drugs for attention-deficit and hyperactivity disorder.
